Patent Assignment
Reel/Frame 069291/0350
Change of Name
Recorded: 2024-11-01
Pages: 4
Assignor
OCUPHIRE PHARMA, INC.
Executed: 2024-10-22
Assignee
OPUS GENETICS, INC.
37000 GRAND RIVER AVE., SUITE 120, FARMINGTON HILLS, MICHIGAN, 48335
Covered Properties
(3)
Methods and Compositions for Treatment of Glaucoma and Related Conditions
Methods and Compositions for Treatment of Mydriasis
Methods and Compositions for Treatment of Mydriasis
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 29, 2021
From: PITLICK, WILLIAM H.; MEYER, ALAN R.; SOOCH, MINA; CHARIZANIS, KONSTANTINOS
To: OCUPHIRE PHARMA, INC.
Reel/Frame 057644/0277 →
Assignment of Assignor's Interest
Oct 5, 2022
From: PITLICK, WILLIAM H.; MEYER, ALAN R.; SOOCH, MINA; CHARIZANIS, KONSTANTINOS
To: OCUPHIRE PHARMA, INC.
Reel/Frame 061321/0365 →
Assignment of Assignor's Interest
Oct 6, 2022
From: PITLICK, WILLIAM H.; MEYER, ALAN R.; SOOCH, MINA; CHARIZANIS, KONSTANTINOS
To: OCUPHIRE PHARMA, INC.
Reel/Frame 061339/0815 →
Security Interest
Apr 21, 2026
From: OPUS GENETICS, INC.
To: OPCM SA LLC, AS PURCHASER AGENT FOR THE SECURED PARTIES
Reel/Frame 075478/0138 →